Anatomic Stage II Breast Cancer AJCC V8

Pipeline Programs↗

Active Trials↗

Companies Involved↗

Anatomic Stage II Breast Cancer AJCC v8 is an early-stage landscape with 0 programs across 0 companies.

Intelligence

Pipeline Metrics

Competitive Density

21/100

Pipeline Velocity

6/100

Mech. Concentration

N/A

Completion Rate

N/A

Attrition Rate

0/100

Pipeline

No pipeline programs currently tracked for this disease.

Analysis

clinical trials

Recruiting4 · 67%

Active, not recruiting2 · 33%

Clinical Trials

6 trials

Recruiting·National Cancer Institute (NCI)·Phase 3·NCT07391774·1,978 enrolled

Recruiting·National Cancer Institute (NCI)·Phase 3·NCT06058377·3,680 enrolled

Recruiting·MMayo Clinic·Phase 1·NCT06999798·20 enrolled

Recruiting·Alliance for Clinical Trials in Oncology·Phase 3·NCT05812807·1,295 enrolled

Active, not recruiting·ECOG-ACRIN Cancer Research Group·Phase 2·NCT05710328·235 enrolled

Active, not recruiting·ECOG-ACRIN Cancer Research Group·Phase 2·NCT04266249·2,175 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)